A lenient approach to heart rate control in atrial fibrillation (AF) is just as effective as the strict approach generally recommended in guidelines, Dutch researchers have found.
Favourable risk factor trends and improvements in therapy each explain about half the substantial decrease in coronary heart disease (CHD) mortality that has occurred in Ontario in recent years.
A Quebec study has shown many myocardial infarction patients are receiving reperfusion therapy outside recommended time windows, and this is putting them at increased risk of dying within 30 days.
A major meta-analysis of fibrate drugs has shown they modestly reduce the risk of major cardiovascular events, mainly through prevention of coronary artery disease and the need for revascularization.
